- Sanofi Starts Tender Offer For Outstanding Chattem Shares (The Wall Street Journal)
- H1N1 Flu Is a False Pandemic, Health Expert Claims (Fox News)
- Novartis Gets Patent For Cancer Drug (Business Standard)
- For the Treatment of Alzheimer’s Disease, Pfizer/Medivation’s Dimebon Will Garner Peak Year Sales of $1.5 Billion (PR Newswire)
- UK Joins Rest of Europe in Shifting Surplus Swine Flu Vaccines (PharmaTimes)
- Sanofi Cuts Lantus Diabetes Drug Cost in Indonesia, Philippines (BusinessWeek)
- Patheon Inc. signs Two 5-year Manufacturing Agreement Renewals With Sanofi-Aventis (PR Newwire)
- Novartis Launches Schizophrenia Treatment Fanapt in the US, Offering Patients an Attractive Alternative to Existing Medications (Novartis Press Release)
- FDA Approves Actemra For Rheumatoid Arthritis (The Wall Street Journal)
- Vical Announces Licensee’s Approval of ONCEPT(TM) Therapeutic Melanoma Vaccine for Dogs (CNN Money)
- Medicis to Present at J.P. Morgan Healthcare Conference (Medicis Press Release)
SUBSCRIBE